Efficacy and Safety of Daridorexant in Older and Younger Adults with Insomnia Disorder: A Secondary Analysis of a Randomised Placebo-Controlled Trial

BACKGROUND AND OBJECTIVE: The dual orexin receptor antagonist daridorexant, studied in two phase III trials, dose-dependently improved objective and subjective sleep variables and daytime functioning in adults with insomnia. Because treatment of insomnia in older adults is challenging and has limite...

Descripción completa

Detalles Bibliográficos
Autores principales: Fietze, Ingo, Bassetti, Claudio L. A., Mayleben, David W., Pain, Scott, Seboek Kinter, Dalma, McCall, William V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553778/
https://www.ncbi.nlm.nih.gov/pubmed/36098936
http://dx.doi.org/10.1007/s40266-022-00977-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553778/
https://www.ncbi.nlm.nih.gov/pubmed/36098936
http://dx.doi.org/10.1007/s40266-022-00977-4

Ejemplares similares